The role of cyclooxygenase-2 and aryl hydrocarbon receptor nuclear translocator in non-small cell lung cancer cells resistant to inhibitors of epidermal growth factor receptor
碩士 === 國立成功大學 === 臨床醫學研究所 === 96 === The development of tyrosine kinase inhibitors (TKI) targeting epidermal growth factor receptor (EGFR) has brought the treatment of non-small cell lung cancer (NSCLC) to a new era. The impressive therapy, however, leads to the development of drug resistance eventu...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/77652641942666724382 |